ClinicalTrials.Veeva

Menu

Clinical Evaluation of the Causes of Contact Lens Related Dry Eye

Alcon logo

Alcon

Status

Completed

Conditions

Contact Lens Related Dry Eye

Treatments

Device: ReNu MultiPlus
Device: Opti-Free RepleniSH
Device: Contact lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT00995189
M-09-03 / DRYS 1302 / IBIS

Details and patient eligibility

About

The purpose of this study was to clinically evaluate the potential causes of contact lens-related dry eye.

Full description

Daily wear soft contact lens wearers reporting significant contact lens-related dryness symptoms were enrolled. Late day dryness with contact lenses, intensity grade 3-5, frequency "sometimes / frequently / constantly" as evaluated by a questionnaire was considered significant.

Enrollment

159 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Reports late-day dryness symptoms with contact lens wear on questionnaire.
  • Wears FDA Group 2 hydrogel, FDA Group 4 hydrogel, or silicone hydrogel lenses.
  • Consistently uses either polyhexamethylene biguanide (PHMB) or polyquaternium-1 (PQT) contact lens care products (i.e. >6 months including 1 month immediately before enrollment).
  • Other protocol-defined inclusion criteria may apply.

Exclusion criteria

  • Wears daily disposable contact lenses.
  • Has significant symptoms related to lens fit or lens deposits.
  • Requires concurrent ocular medication (rewetting drops allowed).
  • Has used Restasis® in the last 3 months.
  • Wears punctal plugs fitted in the last 30 days.
  • Has any current systemic or ocular abnormality, infection or disease.
  • Uses any current systemic medication likely to affect tear film, e.g. antihistamines, betaadrenergic blockers, steroids.
  • Has a history of refractive surgery.
  • Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

159 participants in 2 patient groups

OFR
Experimental group
Description:
Opti-Free RepleniSH contact lens care solution used for 30 days
Treatment:
Device: Opti-Free RepleniSH
Device: Contact lenses
RNM
Active Comparator group
Description:
ReNu MultiPlus contact lens care solution used for 30 days
Treatment:
Device: ReNu MultiPlus
Device: Contact lenses

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems